# An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: Fudan University · Condition: Breast Cancer

- Company: Fudan University
- Sector: Breast Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07117630

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.